Exposure and Health · 8 authors, 6 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This pilot study of 65 mother-newborn pairs found strong correlations between maternal serum levels of BDNF and KISS-1 and both placental gene expression and umbilical cord serum protein levels, suggesting maternal levels could be biomarkers for placental and fetal health.
This pilot cohort study investigated the relationships between brain-derived neurotrophic factor (BDNF) and kisspeptin-1 (KISS-1) levels in maternal serum, umbilical cord, and placenta among 65 mother-newborn pairs. The central finding is that maternal serum levels of both biomarkers are exceptionally well-correlated with placental gene expression and cord serum protein levels, indicating their potential as effect biomarkers for placental health and fetal neurodevelopment. A strength is the hybrid multidisciplinary approach, combining epidemiology with in vitro confirmation using human primary placental cells. Key limitations include the small sample size, requiring validation in larger studies, and the inability to measure other potential chemical confounders due to financial constraints.
